Mitochondrial NADK2‐dependent NADPH controls tau oligomer uptake in human neurons
Alzheimer's & Dementia · 2026-06 · 22 (6)
DOI: 10.1002/alz.71594 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 16.06.2026. Verfasst von Evelyn Pardo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Virginia, Charlottesville, Virginia, USA. Hauptthemen laut MEDLINE: Neurons, tau Proteins, Mitochondria, NADP. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Owens Family Foundation, NIA NIH HHS, University of Virginia's School of Medicine.
Abstract (Originalsprache)
INTRODUCTION Reduced brain energy metabolism, mitochondria dysfunction, and extracellular tau oligomer buildup characterize Alzheimer's disease (AD), but how these phenomena cooperatively promote neurodegeneration is poorly understood. We now report that tau oligomers (TauOs) pathologically coordinate mitochondrial metabolism with increased expression of a plasma membrane (PM) tau receptor. METHODS Mitochondrial energy metabolism was recorded using two‐photon fluorescence lifetime microscopy of mitochondrial nicotinamide adenine dinucleotide phosphate (NADPH) in live human neurons and PS19 mouse brain. RESULTS Recombinant or human brain‐derived TauOs upregulate expression of the mitochondrial NAD+ kinase, mitochondrial NAD kinase 2 (NADK2), and by extension, de novo NADPH synthesis. This process controls expression of low‐density lipoprotein receptor‐related protein 1 (LRP1), a major PM receptor for tau, thereby establishing a vicious cycle for further TauO internalization. Upregulation of the NADK2‐NADPH pathway was detected in live presymptomatic PS19 mouse brains and in AD patient‐derived neurons. DISCUSSION Upregulation of mitochondrial NADK2‐dependent NADPH controls a key step in TauO toxicity and may represent an early stage in human AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Virginia, Charlottesville, Virginia, USA.
- W.M. Keck Center for Cellular Imaging, University of Virginia, Charlottesville, Virginia, USA.
- Center for Brain Immunology and Glia, Department of Neuroscience, University of Virginia, Charlottesville, Virginia, USA.
- Department of Cell Biology, University of Virginia, Charlottesville, Virginia, USA.
- Department of Neuroscience, University of Virginia, Charlottesville, Virginia, USA.
ORCID-Profile: Andrés Norambuena
Förderung
- Owens Family Foundation
- NIA NIH HHS
- University of Virginia's School of Medicine
- Cure Alzheimer's Fund
- NIH Office of the Director
- Rick Sharp Alzheimer's Foundation
- National Institute on Aging
Zitieren
APA
Pardo, E., Kim, T., Wallrabe, H., Zengeler, K. E., Sagar, V. K., Mingledorff, G., Sun, X., Periasamy, A., Lukens, J. R., Bloom, G. S., & Norambuena, A. (2026). Mitochondrial NADK2‐dependent NADPH controls tau oligomer uptake in human neurons. Alzheimer's & Dementia, 22(6). https://doi.org/10.1002/alz.71594
Vancouver
Pardo E, Kim T, Wallrabe H, Zengeler KE, Sagar VK, Mingledorff G, et al. Mitochondrial NADK2‐dependent NADPH controls tau oligomer uptake in human neurons. Alzheimer's & Dementia. 2026;22(6). doi:10.1002/alz.71594
BibTeX
@article{Pardo2026,
author = {Pardo, Evelyn and Kim, Taylor and Wallrabe, Horst and Zengeler, Kristine E and Sagar, Vijay Kumar and Mingledorff, Garnett and Sun, Xuehan and Periasamy, Ammasi and Lukens, John R and Bloom, George S and Norambuena, Andrés},
title = {Mitochondrial NADK2‐dependent NADPH controls tau oligomer uptake in human neurons},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {6},
doi = {10.1002/alz.71594}
}
EUVIMED